Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-13
Publisher
Hindawi Limited
Online
2015-09-07
DOI
10.1155/2015/690492
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bioanalysis of 6-diazo-5-oxo-l-norleucine in plasma and brain by ultra-performance liquid chromatography mass spectrometry
- (2015) Jesse Alt et al. ANALYTICAL BIOCHEMISTRY
- Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer
- (2015) Tiejun Pan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A nexus for cellular homeostasis: the interplay between metabolic and signal transduction pathways
- (2015) Ana P Gomes et al. CURRENT OPINION IN BIOTECHNOLOGY
- Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids
- (2015) DIANA CERVANTES-MADRID et al. ONCOLOGY REPORTS
- Antagonizing Bcl-2 Family Members Sensitizes Neuroblastoma and Ewing’s Sarcoma to an Inhibitor of Glutamine Metabolism
- (2015) Rachelle R. Olsen et al. PLoS One
- PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells
- (2014) Haili Wu et al. CELLULAR SIGNALLING
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes
- (2014) Rouhallah Najjar Sadeghi et al. TUMOR BIOLOGY
- Structural Basis for the Active Site Inhibition Mechanism of Human Kidney-Type Glutaminase (KGA)
- (2014) K. Thangavelu et al. Scientific Reports
- Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors
- (2013) Ajit G. Thomas et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A growing role for mTOR in promoting anabolic metabolism
- (2013) Jessica J. Howell et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer
- (2013) B. Li et al. CLINICAL CANCER RESEARCH
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Tumor glycolysis as a target for cancer therapy: progress and prospects
- (2013) Shanmugasundaram Ganapathy-Kanniappan et al. Molecular Cancer
- Signal integration by mTORC1 coordinates nutrient input with biosynthetic output
- (2013) Christian C. Dibble et al. NATURE CELL BIOLOGY
- Metabolic sensors and their interplay with cell signalling and transcription
- (2012) Alena Krejčí BIOCHEMICAL SOCIETY TRANSACTIONS
- Anticancer Agents That Counteract Tumor Glycolysis
- (2012) Carlotta Granchi et al. ChemMedChem
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
- (2011) Brian Magnuson et al. BIOCHEMICAL JOURNAL
- Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
- (2011) D. Gaglio et al. Molecular Systems Biology
- Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
- (2011) Christian M. Metallo et al. NATURE
- Choosing between glycolysis and oxidative phosphorylation: A tumor's dilemma?
- (2010) Caroline Jose et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells
- (2010) Meng Meng et al. CELL CYCLE
- Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
- (2010) Jennifer F Barger et al. ENDOCRINE-RELATED CANCER
- Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model
- (2010) Laura M. Shelton et al. INTERNATIONAL JOURNAL OF CANCER
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
- (2010) A. J. Levine et al. SCIENCE
- Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling
- (2009) C. Yang et al. CANCER RESEARCH
- Incremental Advance or Seismic Shift? The Need to Raise the Bar of Efficacy for Drug Approval
- (2009) Alberto Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer
- (2008) S. J. Yeung et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
- (2008) N Goldin et al. ONCOGENE
- Disruption of the hexokinase–VDAC complex for tumor therapy
- (2008) L Galluzzi et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started